Company / Current Assets per Share
Cogent Biosciences, Inc. Current Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$7.06
FY2025
5-year range
$2.85 / $7.06
FY2021-FY2025
Trend
+147.4%
vs FY2024
Sector context
#100 of 210
Health Care
What the data says
At $7.06, Cogent Biosciences, Inc.'s current assets per share ranks #100 of 210 in the Health Care sector. Current Assets per Share returned to growth in FY2025 after 4 years of decline, reaching $7.06.
Based on SEC 10-K filings.
7.06 in FY2025 with a 5-year CAGR of -20.4%.
Improved from $3.40 to $7.06 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +16.1%
- 5-Year CAGR
- -20.4%
- 10-Year CAGR
- -
Sector benchmark
#100 of 210 in Health CareTop 48% of 210This company $7.06 Sector average $170.46
▼
-95.9% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 147.4% year-over-year.
- Ranks #100 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.06 | +147.4% |
| FY2024 | $2.85 | -16.0% |
| FY2023 | $3.40 | -24.6% |
| FY2022 | $4.51 | -21.5% |
| FY2021 | $5.75 | -74.0% |
| FY2020 | $22.10 | +314.9% |
| FY2019 | $5.33 | +63.7% |
| FY2018 | $3.25 | -21.8% |
| FY2017 | $4.16 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026